OpenEye Scientific is now part of Cadence

miniCUP Tokyo 2025

miniCUP Tokyo 2025

miniCUP Tokyo 2025 will be held on October 14th, 2025



OpenEye's miniCUP series brings our latest scientific advancements to you. Our upcoming miniCUP Tokyo is a single-day in-person gathering that will provide the opportunity to hear presentations from OpenEye and industry speakers, as well as to learn about the recent updates to the Orion® molecular design platform and our applications and toolkits. Come for the science, and stay for robust discussion at a cocktail reception following the event.

Location:
Station Conference Tokyo
100-0005 1-7-12 Sapia Tower
Marunouchi, Chiyoda-ku, Tokyo

Event Agenda:
10:00 Registration & Coffee/Tea

Foundations:
10:30 Opening remarks – Louis Culot, CVP, Molecular Sciences Group

11:00 Molecular shape and color: Unifying principles for success in drug discovery – Paul Hawkins, Product Evangelist

11:30 Understanding and Predicting the Membrane Permeability of CyclicPeptides Based on Large-Scale Data - Shinsuke Sando, The University of Tokyo

Networking Lunch

Platform Advances:
13:00 Empower your chemists with interactive Molecule Search – Koji Oda, Application Scientist

13:15 Click. Compute. Cure? Enabling modern computational design – Jeff Grandy, VP Sales

Target Exploration:
13:30 Pocket ligandability: identifying actionable cryptic pockets across the druggable proteome – David LeBard, Scientific Software Director

14:00 Identification & exploration of novel sites for covalent docking – David LeBard, Scientific Software Director

Coffee/Tea break

Hit Identification:
15:00 Don’t miss your next blockbuster: ROCS X for trillion-scale 3D virtual screening of accessible and novel chemical space – Matt Geballe, Group Director, Scientific Research and Development

15:30 OMEGA: State of the art conformer generation with Bayesian sampling – Caitlin Bannan, Manager, Scientific Research and Development

Coffee/Tea break

Lead Discovery & Optimization:
16:30 Boltz2 benchmark on in-house dataset: thinking of how to effectively use in drug discovery campaigns - Akitoshi Okada, Daiichi Sankyo

17:00 ML-Enabled integration of affinity prediction and lead discovery: 3D-QSAR – Paul Hawkins, Product Evangelist

17:30 Free energy prediction for drug discovery: Ideas at breakfast, discoveries by lunch – Chris Neale, Manager Affinity Group

Closing & Reception:
18:00 Closing Remarks

Reception: Cocktails and refreshments

 

Registration for miniCUP Tokyo is now open. Reserve your spot today! 

Register